This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n17http://localhost/temp/predkladatel/
n20http://linked.opendata.cz/resource/domain/vavai/projekt/
n12http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n14http://linked.opendata.cz/resource/domain/vavai/subjekt/
n13http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n10http://bibframe.org/vocab/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61989592%3A15310%2F12%3A33141331%21RIV13-MSM-15310___/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n19http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n5http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n21http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n15http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61989592%3A15310%2F12%3A33141331%21RIV13-MSM-15310___
rdf:type
n13:Vysledek skos:Concept
rdfs:seeAlso
http://www.sciencedirect.com/science/article/pii/S1359644611004375
dcterms:description
The effort to repurpose old drugs for new uses is not sufficient; even drugs that have been used clinically for decades must undergo expensive clinical trials. This process requires the pharmaceutical industry to fund the repatenting of old drugs. Because inexpensive drugs are necessary for people around the world, attempts should be made to develop nonprofit drugs through clinical trials of generic drugs that are funded by governments and charities. Evidence supports the use the old anti-alcoholic drug Antabuse as a new nonprofit drug for cancer. The effort to repurpose old drugs for new uses is not sufficient; even drugs that have been used clinically for decades must undergo expensive clinical trials. This process requires the pharmaceutical industry to fund the repatenting of old drugs. Because inexpensive drugs are necessary for people around the world, attempts should be made to develop nonprofit drugs through clinical trials of generic drugs that are funded by governments and charities. Evidence supports the use the old anti-alcoholic drug Antabuse as a new nonprofit drug for cancer.
dcterms:title
Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram) Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
skos:prefLabel
Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram) Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)
skos:notation
RIV/61989592:15310/12:33141331!RIV13-MSM-15310___
n13:predkladatel
n14:orjk%3A15310
n3:aktivita
n5:P
n3:aktivity
P(EE.2.3.20.0062)
n3:cisloPeriodika
9-10
n3:dodaniDat
n15:2013
n3:domaciTvurceVysledku
n12:9131795
n3:druhVysledku
n21:J
n3:duvernostUdaju
n19:S
n3:entitaPredkladatele
n7:predkladatel
n3:idSjednocenehoVysledku
154426
n3:idVysledku
RIV/61989592:15310/12:33141331
n3:jazykVysledku
n9:eng
n3:klicovaSlova
infection; paromomycin; ditiocarb; proteasome; inhibition; double-blind; existing drugs; diethyldithiocarbamate therapy; visceral leishmaniasis; breast-cancer
n3:klicoveSlovo
n6:paromomycin n6:double-blind n6:infection n6:existing%20drugs n6:ditiocarb n6:inhibition n6:proteasome n6:visceral%20leishmaniasis n6:breast-cancer n6:diethyldithiocarbamate%20therapy
n3:kodStatuVydavatele
GB - Spojené království Velké Británie a Severního Irska
n3:kontrolniKodProRIV
[AC5E75B272A8]
n3:nazevZdroje
Drug Discovery Today
n3:obor
n16:FR
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
1
n3:projekt
n20:EE.2.3.20.0062
n3:rokUplatneniVysledku
n15:2012
n3:svazekPeriodika
17
n3:tvurceVysledku
Cvek, Boris
n3:wos
000304297100002
s:issn
1359-6446
s:numberOfPages
4
n10:doi
10.1016/j.drudis.2011.12.010
n17:organizacniJednotka
15310